A precision fermentation technology leveraging yeast to produce peptides that enhance hair retention, promote growth, and restore natural hair color. Ready for clinical trials, this solution offers innovative applications in hair care.
2D LLC presents an innovative solution in the field of hair care using precision fermentation technology. This approach utilizes yeast to manufacture a wide range of peptides, from 2 to 3,400 amino acids in length, aimed at enhancing hair retention, promoting hair growth, and restoring natural hair color. The technology has been under development for over 20 years, showcasing its potential to revolutionize the hair care industry by offering targeted and effective solutions for hair health.
Key features:
This technology is at TRL 5, indicating that it has been validated in a relevant environment and is ready to proceed to clinical trials. The majority of peptides are manufactured, and the research phase is complete, positioning the technology for further development and commercialization.
CopX is a United States-based corporation focused on biotechnology and wellness products, including functional proteins, exosome preparations, and healthspan monitoring technologies. The company utilizes precision fermentation to produce proteins at scale, drawing on international research expertise to develop products aimed at supporting cellular function and mitigating age-related decline. Their portfolio includes 2D Functional Proteins, which are targeted blends designed to replenish essential peptides, and 2D Exomax, an exosome preparation derived from human umbilical cord mesenchymal stem cells for regenerative science applications. The company also promotes the 2DHeal network, which integrates health assessments such as AI-powered retinal imaging—using Airdoc camera technology—with their product offerings to provide personalized wellness insights.
By leveraging advanced manufacturing and diagnostic tools, CopX aims to support professional and research applications in health and integrative medicine. The company maintains international operational facilities for manufacturing and research, emphasizing scalability and sustainable production methods. Their model involves providing high-quality biological materials and screening services to health professionals and partners worldwide, focusing on addressing chronic inflammatory and degenerative health challenges. Through strategic collaborations and a emphasis on continuous production, CopX seeks to facilitate advancements in areas ranging from alternative proteins to biopharmaceuticals and personalized anti-aging protocols.